Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Damon A. Hofman"'
Autor:
Mireia Palomar-Siles, Angelos Heldin, Meiqiongzi Zhang, Charlotte Strandgren, Viktor Yurevych, Jip T. van Dinter, Sem A. G. Engels, Damon A. Hofman, Susanne Öhlin, Birthe Meineke, Vladimir J. N. Bykov, Sebastiaan van Heesch, Klas G. Wiman
Publikováno v:
Cell Death and Disease, Vol 13, Iss 11, Pp 1-17 (2022)
Abstract TP53 nonsense mutations in cancer produce truncated inactive p53 protein. We show that 5-FU metabolite 5-Fluorouridine (FUr) induces full-length p53 in human tumor cells carrying R213X nonsense mutant TP53. Ribosome profiling visualized tran
Externí odkaz:
https://doaj.org/article/d20df1692ffe43d69b4b2923e7b6b3b8
Autor:
Judith Wienke, S Nierkens, Miranda P Dierselhuis, Jan J Molenaar, Annelisa M Cornel, Ester Dunnebach, Damon A Hofman, Sanjukta Das, Satyaki Sengupta, Femke van den Ham, Josephine G M Strijker, Denise A M H van den Beemt, Anke H W Essing, Bianca Koopmans, Sem A G Engels, Vania Lo Presti, Celina S Szanto, Rani E George, Sebastiaan van Heesch
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
Background Immunotherapy in high-risk neuroblastoma (HR-NBL) does not live up to its full potential due to inadequate (adaptive) immune engagement caused by the extensive immunomodulatory capacity of HR-NBL. We aimed to tackle one of the most notable
Externí odkaz:
https://doaj.org/article/7142ba69053342a98bcc3622acf2b968
Autor:
Ruben van Boxtel, Mirjam E. Belderbos, Joske Ubels, Freek Manders, Mark Verheul, Rurika Oka, Damon A. Hofman, Markus J. van Roosmalen, Eline J.M. Bertrums, Arianne M. Brandsma
Overview of supplementary data of this manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d52f7bb39b4fdd69d494d7bbd74cf2cd
https://doi.org/10.1158/2643-3230.22543156.v1
https://doi.org/10.1158/2643-3230.22543156.v1
Autor:
Ruben van Boxtel, Mirjam E. Belderbos, Joske Ubels, Freek Manders, Mark Verheul, Rurika Oka, Damon A. Hofman, Markus J. van Roosmalen, Eline J.M. Bertrums, Arianne M. Brandsma
Supplementary Figures S1-S6 with figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1efcacdc11519bb33bce4d29d7f6ba
https://doi.org/10.1158/2643-3230.22543159.v1
https://doi.org/10.1158/2643-3230.22543159.v1
Autor:
Ruben van Boxtel, Mirjam E. Belderbos, Joske Ubels, Freek Manders, Mark Verheul, Rurika Oka, Damon A. Hofman, Markus J. van Roosmalen, Eline J.M. Bertrums, Arianne M. Brandsma
Supplementary Table S1-10 providing details on study cohorts and sequencing results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604bd120ff80da895a88fc9deab43276
https://doi.org/10.1158/2643-3230.22543153.v1
https://doi.org/10.1158/2643-3230.22543153.v1
Autor:
Ruben van Boxtel, Mirjam E. Belderbos, Joske Ubels, Freek Manders, Mark Verheul, Rurika Oka, Damon A. Hofman, Markus J. van Roosmalen, Eline J.M. Bertrums, Arianne M. Brandsma
Acquisition of oncogenic mutations with age is believed to be rate limiting for carcinogenesis. However, the incidence of leukemia in children is higher than in young adults. Here we compare somatic mutations across pediatric acute myeloid leukemia (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691d34e613ed0a121287422ff56513f1
https://doi.org/10.1158/2643-3230.c.6550159
https://doi.org/10.1158/2643-3230.c.6550159
Autor:
Annelisa M Cornel, Ester Dunnebach, Damon A Hofman, Sanjukta Das, Satyaki Sengupta, Femke van den Ham, Judith Wienke, Josephine G M Strijker, Denise A M H van den Beemt, Anke H W Essing, Bianca Koopmans, Sem A G Engels, Vania Lo Presti, Celina S Szanto, Rani E George, Jan J Molenaar, Sebastiaan van Heesch, Miranda P Dierselhuis, S Nierkens
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005002
BackgroundImmunotherapy in high-risk neuroblastoma (HR-NBL) does not live up to its full potential due to inadequate (adaptive) immune engagement caused by the extensive immunomodulatory capacity of HR-NBL. We aimed to tackle one of the most notable